Dysplasia in Barrett's esophagus - Intra- and interobserver variability in histopathological diagnosis;Displasia no esôfago de Barrett - Concordância intra e interobservador no diagnóstico histopatológico

Arquivos de Gastroenterologia

Volumn 41, Issue 2, 2004, Pages 79-83

  Lopes, César Vivian ^a,e   Pereira Lima, Júlio C ^b   Hartmann, Antônio Atalíbio ^c   Tonelotto, Eunice ^d   Salgado, Karina ^c  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b Departamento de Gastroenterologia   (Brazil)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^d FUGAST   (Brazil)

^e NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; DYSPLASIA; ENDOSCOPY; ESOPHAGUS BIOPSY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROSCOPE; PERIODIC ACID SCHIFF STAIN; PRECANCER; REPRODUCIBILITY;

EID: 7044232904     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032004000200002     Document Type: Article

References (25)

1. Alikhan M, Rex D, Khan A, Rahmani E, Cummings O, Ulbright TM. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc 1999;50:23-6.
2. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-94.
3. Cameron AJ. Management of Barrens esophagus. Mayo Clin Proc 1998;73:457-61.
4. Canto MI. Vital staining and Barrett's esophagus. Gastrointest Endosc 1999;49:S12-S6.
5. Canto MI, Setrakian S, Willisje, Chak A, Petras RE, Sivak MV. Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study. Endoscopy 2001;33:391-400.
6. Castell DO, Katzka DA. Barrett's esophagus: continuing questions and controversy. Gastrointest Endosc 1999;49:S5-S8.
7. Daly JM, Fry WA, Little AG, Winchester DP, Mckee RF, Stewart AK, Fremgen AM. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 2000;190:548-59.
8. rd ed. New York: Lange Medical Books/McGraw-Hill; 2001.
9. DeMeester SR, DeMeester TR. Columnar mucosa and Intestinal metaplasia of the esophagus: fifty years of controversy. Ann Surg 2000;231:303-321.
10. Geboes K, Van Eyken P. The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000;37:99-107.
11. Katz D, Rothstein R, Schned A, Dunn J, Seaver K, Antonioli D. The Development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998;93:536-41.
12. Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus. Mayo Clin Proc 2001;76:438-46.
13. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lcwin DN, Robert ME, Toledano AY, Shyr Y, Washington K. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 2001;32:368-78.
14. Morales TG, Sampliner RE. Barrett's esophagus: update on screening, surveillance, and treatment. Arch Intern Med 1999;159:1411-6.
15. O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus. Am J Gastroenterol 1999;94:2037-42.
16. Ortiz-Hidalgo C, De la Vega G, Aguirre-Garcia J. The histopathology and biologic prognostic factors of Barrett's esophagus. J Clin Gastroentcrol 1998;26:324-33.
17. Rajan E, Burgart LJ, Gostout CJ. Endoscopic and histologic diagnosis of Barrett esophagus. Mayo Clin Proc 2001;76:217-25.
18. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
19. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline hislology and flow cytometry identify low-and high-risk patients subsets. Am J Gastroenterol 2000;95:1669-76.
20. Sampliner RE, The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
21. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Preiser CM, Flejou JF, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner FA, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H. The Vienna Classification of Gastrointestinal Epithelial Neoplasia. Gut 2000;47:251-5.
22. Skacel M, Petras RE, Gramlich TL, Sigel JE, Richter JE, Goldblum JR. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000;95:3383-7.
23. Skacel M, Petras RE, Rybicki LA, Gramlich TL, Richter JE, Falk GW, Goldblum JR. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression. Am J Gastroenterol 2002;97:2508-13.
24. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopie, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999;94:3413-9.
25. Wijnhoven BPL, Tilanus HW, Dinjens WNM. Molecular biology of Barrett's adenocarcinoma. Ann Surg 2001;233:322-37.